chr7-93101360-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_017654.4(SAMD9):c.4738G>A(p.Gly1580Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000496 in 1,613,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. G1580G) has been classified as Likely benign.
Frequency
Consequence
NM_017654.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SAMD9 | NM_017654.4 | c.4738G>A | p.Gly1580Ser | missense_variant | 3/3 | ENST00000379958.3 | |
SAMD9 | NM_001193307.2 | c.4738G>A | p.Gly1580Ser | missense_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SAMD9 | ENST00000379958.3 | c.4738G>A | p.Gly1580Ser | missense_variant | 3/3 | 1 | NM_017654.4 | P1 | |
SAMD9 | ENST00000620985.4 | c.4738G>A | p.Gly1580Ser | missense_variant | 2/2 | 2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152058Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 251022Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135718
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461028Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 726852
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152058Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74268
ClinVar
Submissions by phenotype
SAMD9-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 17, 2024 | The SAMD9 c.4738G>A variant is predicted to result in the amino acid substitution p.Gly1580Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0047% of alleles in individuals of European (Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 29, 2023 | This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 1580 of the SAMD9 protein (p.Gly1580Ser). This variant is present in population databases (rs776490364, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with SAMD9-related conditions. ClinVar contains an entry for this variant (Variation ID: 1987222). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SAMD9 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at